SP TRIO FORTE TABLET

Product Description

Product Name: SP TRIO FORTE TABLET
Composition: Sitagliptin 100mg + Dapagliflozin 10mg + Metformin 500mg

Product Description for Trade India & B2B Platforms:

SP TRIO FORTE TABLET is a next-generation oral antidiabetic formulation that combines Sitagliptin 100mg, Dapagliflozin 10mg, and Metformin 500mg for effective and comprehensive Type 2 Diabetes Mellitus management. This triple-action therapy offers synergistic glucose control through complementary mechanisms, making it ideal for medical distributors, bulk buyers, and retailers seeking a high-demand, result-driven product for diabetic care.

Key Benefits:

• Triple Mechanism of Action:
  Sitagliptin (DPP-4 inhibitor): Enhances insulin release and reduces glucagon levels
  Dapagliflozin (SGLT2 inhibitor): Promotes urinary glucose excretion
  Metformin (Biguanide): Reduces hepatic glucose production and improves insulin sensitivity

• Effective HbA1c Control: Supports better glycemic outcomes with fewer fluctuations.

• Lower GI Tolerance Dose: 500mg Metformin ensures improved patient compliance.

• Cardiovascular & Renal Support: Dapagliflozin is known to provide additional cardio-renal benefits.

Usage/Application:

• Prescribed for adult patients with Type 2 Diabetes Mellitus who need triple oral therapy.

• Used when dual drug therapy is insufficient to control blood glucose levels.

• To be taken under the supervision of a healthcare provider, ideally with meals.

Why Choose SP TRIO FORTE:

• Balanced formulation for enhanced efficacy with minimized side effects.

• WHO-GMP certified manufacturing for assured quality and safety.

• Available for bulk supply, custom branding, and private labeling.

• High market demand among hospitals, diabetic clinics, and retail pharmacies.